Global Alpha-lactalbumin market has been witnessing strong growth over the past few years on account of its increasing demand from the infant formula market and the trend is expected to continue over the next seven years. alpha-lactalbumin demand is expected to witness lucrative growth over the forecast period on account of superior nutrients composition which closely resembles breast milk nutrients. Alpha-Lactalbumin is rich in amino acids which help in maintaining and optimizing protein levels for infants, which is expected to complement the market growth over the forecast period. Rising birth rates in India and China is expected to drive the infant formula market in Asia Pacific, which in turn is expected to drive the market over the forecast period. In addition, increasing application scope of alpha-lactalbumin in healthy foods and nutrition products is further expected to fuel market growth over the projected period. alpha-lactalbumin being a major ingredient in infant formula is required to be included in the product labeling as per standards. However, these labeling standards differ according to regions thus making it difficult for market players to expand globally.
Based on applications, the market can be segmented into clinical nutrition, infant formula, sports nutrition, and healthy foods. Infant formula emerged as the leading application segment for α-lactalbumin market in 2013 and the trend is expected to continue over the forecast period. alpha-lactalbumin as a whey protein is rich in amino acid tryptophan and is widely used in premium infant formulas, increasing consumption of which in emerging economies is expected to be a key factor to drive the market growth in this segment. Application of alpha-lactalbumin in healthy foods is expected to witness strong growth over the next seven years owing to its nutritional benefits and rich composition of amino acids. Sports and clinical nutrition segments are expected to witness considerable growth owing to its special properties which can minimize oxidative stress in the human body. Other niche applications of alpha-lactalbumin include beverages, dietary supplements, confectionery & chocolates, meat, ready-to-eat foods, and bakery products.
Dairy products emerged as the leading end-use industry for the alpha-lactalbumin market in 2013 owing to its increased application in infant formula. alpha-lactalbumin provides immense nutritional benefits to infants which is the key factor to drive the market in this end-use segment. Other end-use industries including food & beverages, pharmaceutical, and nutritional products are expected to witness significant growth over the forecast period on account of numerous health benefits associated with alpha-lactalbumin.
Asia Pacific was the largest market for α-lactalbumin in 2013 followed by North America and Europe. Asia Pacific is expected to remain the largest regional market over the next seven years on account of increasing birth rates in India and China. North America and Europe are expected to witness significant growth over the forecast period owing to strong demand from the infant formula market in these regions.
Major players in the alpha-lactalbumin market include Arla Foods Ingredients, Davisco Foods International, Inc., Sigma-Aldrich Corporation, Sinopharm, Shanghai Yuanye Biotechnology Co., Ltd., and Guangzhou Isun Pharmaceutical Co., Ltd.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
The demand for nutraceuticals & functional foods is expected to witness an upward surge owing to consumers opting for immunity boosting supplements during the COVID-19 pandemic. Furthermore, a decline in the consumption of poultry, meat and seafood products across the globe is expected to increase the demand for plant and animal-based protein supplements in the near future. The report will account for Covid19 as a key market contributor.